References
- Nastri CO, Teixeira DM, Moroni RM, et al. Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention. Ultrasound Obstet Gynecol. 2015;45(4):377–393.
- Feinberg EC. Ovarian hyperstimulation: past, present, and future. Fertil Steril. 2016;106(6):1330.
- Medicine PCotASfR. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril. 2016;106:1634–1647.
- Nouri K, Haslinger P, Szabo L, et al. Polymorphisms of VEGF and VEGF receptors are associated with the occurrence of ovarian hyperstimulation syndrome (OHSS)-a retrospective case-control study. J Ovarian Res. 2014;7:54.
- Li Y, Fang L, Zhang R, et al. Melatonin stimulates VEGF expression in human granulosa-lutein cells: a potential mechanism for the pathogenesis of ovarian hyperstimulation syndrome. Mol Cell Endocrinol. 2020;518:110981.
- Haas J, Bassil R, Gonen N, et al. The VEGF and PEDF levels in the follicular fluid of patients co- treated with LETROZOLE and gonadotropins during the stimulation cycle. Reprod Biol Endocrinol. 2018;16(1):54.
- Grossman LC, Michalakis KG, Browne H, et al. The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome. Fertil Steril. 2010;94(4):1392–1398.
- Zhang L, Rui YC, Yang PY, et al. Inhibitory effects of ginkgo biloba extract on vascular endothelial growth factor in rat aortic endothelial cells. Acta Pharmacol Sin. 2002;23(10):919–923.
- Tulsulkar J, Glueck B, Hinds TD Jr, et al. Ginkgo biloba extract prevents female mice from ischemic brain damage and the mechanism is independent of the HO1/wnt pathway. Transl Stroke Res. 2016;7(2):120–131.
- Ujioka T, Matsuura K, Kawano T, et al. Role of progesterone in capillary permeability in hyperstimulated rats. Hum Reprod. 1997;12(8):1629–1634.
- Wang N, Ma Y, Liu Z, et al. Hydroxytyrosol prevents PM2.5-induced adiposity and insulin resistance by restraining oxidative stress related NF-κB pathway and modulation of gut microbiota in a murine model. Free Radic Biol Med. 2019;141:393–407.
- Itatani Y, Kawada K, Yamamoto T, et al. Resistance to anti-angiogenic therapy in cancer-alterations to anti-VEGF pathway. IJMS. 2018;19(4):1232.
- Şanlı C, Atılgan R, Kuloğlu T, et al. Transient receptor potential melastatin 2 ion channel activity in ovarian hyperstimulation syndrome physiopathology. Turk J Med Sci. 2021;51(2):787–795.
- Atilgan R, Pala Ş, Yavuzkır Ş, et al. What is the impact of short- and long-term supplementation of either cabergoline or clarithromycin on resolving rat ovarian hyperstimulation syndrome (OHSS) model? J Obstet Gynaecol. 2019;39(5):687–694.
- Soares SR, Gómez R, Simón C, et al. Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome. Hum Reprod Update. 2008;14(4):321–333.
- Gómez R, Simón C, Remohí J, et al. Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade. Endocrinology. 2002;143(11):4339–4348.
- Gómez R, Simón C, Remohí J, et al. Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability. Biol Reprod. 2003;68(6):2164–2171.
- Singh SK, Srivastav S, Castellani RJ, et al. Neuroprotective and antioxidant effect of ginkgo biloba extract against AD and other neurological disorders. Neurotherapeutics. 2019;16(3):666–674.